-
In this prospective, randomized, placebo-controlled trial from the Netherlands, 6,771 patients were screened on admission to the hospital for the presence of Staphylococcus aureus nasal colonization using real-time PCR. Of those, 1,251 patients were positive for S. aureus and 917 were included in the intent-to-treat analysis.
-
In October 2009, the US FDA approved Cervarix, a bivalent vaccine containing the oncogenic HPV types 16 and 18, for the prevention of cervical cancer and precancerous lesions in females ages 10 years through 25 years.
-
Malaria is one of the most important diagnostic considerations in febrile returned travelers and can be fatal if not appropriately diagnosed and treated.
-
Click here for the February 2010 Clinical Briefs in Primary Care supplement
-
A longitudinal study of hospitalized WNV patients in Houston was initiated in 2002. A total of 112 patients remain in the cohort.
-
Nearly half of the world's population live in malaria-endemic geographic regions, and more than one million African children die of malaria each year. Vaccine development continues.
-
Eleven heroin users in Northern England and Scotland, as well as a possible twelfth, have been diagnosed with anthrax infection; five have died.
-
n this issue: Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions.
-
The Centers for Disease Control and Prevention has completed a massive update and revision of its 1981 guidelines to prevent catheter-associated urinary tract infections (CA-UTIs).
-
The Centers for Disease Control and Prevention recommends that infection preventionists implement quality improvement (QI) programs or strategies to enhance appropriate use of indwelling catheters and to reduce the risk of CA-UTI based on a facility risk assessment.
